Full text
PDFPage 496
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acocella G., Brumfitt W., Hamilton-Miller J. M. Evidence that rifampicin can be used safely for non-tuberculous diseases. Thorax. 1980 Oct;35(10):788–791. doi: 10.1136/thx.35.10.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Acocella G., Hamilton-Miller J. M., Brumfitt W. Can rifampicin use be safely extended? Evidence for non-emergence of resistant strains of Mycobacterium tuberculosis. Lancet. 1977 Apr 2;1(8014):740–742. doi: 10.1016/s0140-6736(77)92179-1. [DOI] [PubMed] [Google Scholar]
- Brumfitt W., Dixson S., Hamilton-Miller J. M. Use of rifampin for the treatment of urinary tract infections. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S573–S582. doi: 10.1093/clinids/5.supplement_3.s573. [DOI] [PubMed] [Google Scholar]
- Brumfitt W., Hamilton-Miller J. M., Wood A. Failure to stimulate antibodies in man after 7 days' high-dose treatment with rifampicin. Lancet. 1981 Oct 17;2(8251):865–865. doi: 10.1016/s0140-6736(81)91123-5. [DOI] [PubMed] [Google Scholar]
- Girling D. J. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother. 1977 Mar;3(2):115–132. doi: 10.1093/jac/3.2.115. [DOI] [PubMed] [Google Scholar]
- Grosset J., Leventis S. Adverse effects of rifampin. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S440–S450. doi: 10.1093/clinids/5.supplement_3.s440. [DOI] [PubMed] [Google Scholar]
- Kissling M., Bergamini N. Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review). Chemotherapy. 1981;27(5):368–402. doi: 10.1159/000238006. [DOI] [PubMed] [Google Scholar]
- Pattyn S. R., Janssens L., Bourland J., Saylan T., Davies E. M., Grillone S., Feracci C. Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy. Int J Lepr Other Mycobact Dis. 1984 Mar;52(1):1–6. [PubMed] [Google Scholar]
- Scheuer P. J., Summerfield J. A., Lal S., Sherlock S. Rifampicin hepatitis. A clinical and histological study. Lancet. 1974 Mar 16;1(7855):421–425. doi: 10.1016/s0140-6736(74)92381-2. [DOI] [PubMed] [Google Scholar]